Drug Regulation
Drug Control Governance: Regulatory Bodies and Their Impact
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
FDA Approved Drugs: Changes to Approved Drugs
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Drug Products: Biologics, Biosimilars and Interchangeables
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Pekka Kurki1, Marie-Christine Bielsky2,
1Finnish Medicines Agency (FIMEA), Finland.
No abstract available in PubMed .